SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Centene Corp – ‘S-8’ on 1/23/20

On:  Thursday, 1/23/20, at 12:10pm ET   ·   Effective:  1/23/20   ·   Accession #:  1140361-20-1319   ·   File #:  333-236036

Previous ‘S-8’:  ‘S-8’ on 5/3/17   ·   Next:  ‘S-8’ on 5/22/20   ·   Latest:  ‘S-8’ on 1/4/22   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/23/20  Centene Corp                      S-8         1/23/20    7:125K                                   Broadridge Fin’l So… Inc

Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan   —   Form S-8
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration of Securities to be Offered to         HTML     71K 
                Employees Pursuant to an Employee Benefit Plan                   
 2: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     14K 
 3: EX-5.1      Opinion of Counsel re: Legality                     HTML     13K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML      6K 
 5: EX-23.2     Consent of Experts or Counsel                       HTML      6K 
 6: EX-23.3     Consent of Experts or Counsel                       HTML      5K 
 7: EX-23.4     Consent of Experts or Counsel                       HTML      6K 


‘S-8’   —   Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan
Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"24.1

This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 
As filed with the Securities and Exchange Commission on January 23, 2020

Registration No. 333-[●]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM S-8
Registration Statement Under the Securities Act of 1933



CENTENE CORPORATION
(Exact Name Of Registrant As Specified In Its Charter)

Delaware

42-1406317
(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)
 
 
7700 Forsyth Boulevard

(Address of Principal Executive Offices)

(Zip Code)

CENTENE CORPORATION 2012 STOCK INCENTIVE PLAN, AS AMENDED
WELLCARE HEALTH PLANS, INC. 2013 INCENTIVE COMPENSATION PLAN
WELLCARE HEALTH PLANS, INC. 2019 INCENTIVE COMPENSATION PLAN
(Full Title of the Plans)


Keith H. Williamson
Centene Corporation
7700 Forsyth Boulevard
St. Louis, MO 63105
(314) 725-4477
(Name, address and telephone number, including area code, of agent for service)

Copies of all correspondence to:
Paul T. Schnell
Skadden, Arps, Slate, Meagher & Flom LLP
4 Times Square
New York, NY 10036
(212) 735-3000

 Jeremy D. London
Skadden, Arps, Slate, Meagher & Flom LLP
1440 New York Avenue, NW
Washington, DC 20005
(202) 371-7000


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒
Accelerated filer ☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company)
 
Smaller reporting company ☐
Emerging growth company ☐

If an emerging growth company, indicated by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐



CALCULATION OF REGISTRATION FEE

Title of Securities
To be Registered(1)
Amount to be
Registered(2)
Proposed Maximum
Offering Price
Per Share(3)
Proposed Maximum
Aggregate Offering
Price(3)
Amount of
Registration Fee
Centene Corporation Common Stock, par value $0.001 per share (“Common Stock”), issuable upon vesting of assumed time-based restricted stock units and performance-based restricted stock units granted under WellCare Health Plans, Inc.’s 2013 Incentive Compensation Plan
3,336,476
$65.15
$217,371,411.40
$28,214.81
Common Stock, (i) issuable upon vesting of assumed time-based restricted stock units and performance-based restricted stock units granted under WellCare Health Plans, Inc.’s 2019 Incentive Compensation Plan and (ii) reserved for issuance under the Centene Corporation 2012 Stock Incentive Plan, as amended
10,690,990
$65.15
$696,518,007.30
$90,408.04

(1)
Represents shares of Centene Corporation (the “Registrant”) subject to issuance in connection with the Agreement and Plan of Merger among the Registrant, WellCare Health Plans, Inc., Merger Sub I, Inc., and Merger Sub II, Inc., dated as of March 26, 2019.

(2)
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers an indeterminate number of additional shares that may become issuable under the plans identified in the table above by reason of certain corporate transactions or events, including any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of Common Stock.

(3)
Determined on the basis of the average of the high and low sale price of Common Stock as reported on the New York Stock Exchange on January 21, 2020 of $66.09 and $64.21, respectively, solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act.


2

EXPLANATORY NOTE

Centene Corporation (the “Registrant”) is filing this Registration Statement on Form S-8 to register up to 14,027,466 shares of its Common Stock, par value $0.001 per share, issuable in connection with the Centene Corporation 2012 Stock Incentive Plan, as amended (the “Centene Plan”), WellCare Health Plans, Inc.’s 2013 Incentive Compensation Plan (the “2013 Plan”) and 2019 Incentive Compensation Plan (the “2019 Plan” and together with the 2013 Plan, the “Plans”) under the Securities Act of 1933, as amended (the “Securities Act”).

On March 26, 2019, the Registrant, WellCare Health Plans, Inc., Merger Sub I, Inc., a direct wholly owned subsidiary of the Registrant (“Merger Sub I”), and Merger Sub II, Inc., a direct wholly owned subsidiary of the Registrant (“Merger Sub II”) entered into an Agreement and Plan of Merger (the “Merger Agreement”). The Merger Agreement provides that, subject to the terms and conditions set forth therein, Merger Sub I will merge with and into WellCare (the “First Merger”), with WellCare continuing as the surviving corporation and a direct wholly owned subsidiary of the Registrant and, immediately following the completion of the First Merger, WellCare, as the surviving corporation in the First Merger, will merge with and into Merger Sub II, with Merger Sub II continuing as the final surviving corporation and a direct wholly owned subsidiary of the Registrant (the “Second Merger” and together with the First Merger, the “Merger”).

Pursuant to and subject to the terms of the Merger Agreement, the Registrant assumed the Plans in accordance with their terms, including certain time-based restricted stock units and performance-based restricted stock units of WellCare outstanding under the Plans (the “Restricted Stock Units” and “Performance Stock Units,” respectively), which are payable in shares of the Registrant’s Common Stock, subject to the terms and conditions of the underlying award agreements. The aggregate number of the Registrant’s Common Stock subject to the Restricted Stock Units and Performance Stock Units under the 2013 Plan is 3,336,476 shares and under the 2019 Plan is 32,559 shares. In addition, the Registrant has reserved 10,658,431 shares of its Common Stock, which constituted an unused share reserve under the 2019 Plan, that may be issued for future awards granted by the Registrant under the Centene Plan.

Unless the context otherwise requires, references made herein to “Registrant,” “we,” “us,” “our” and “ours” refer to Centene Corporation and its subsidiaries.

PART I

INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS

As permitted by the rules of the Securities and Exchange Commission (“SEC”), this Registration Statement omits the information specified in Part I of Form S-8. The documents containing the information specified in Part I of this Registration Statement will be sent or given to eligible employees as specified by Rule 428(b) promulgated under the Securities Act. Such documents are not being filed with the SEC either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 promulgated under the Securities Act.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.

The following documents listed below for each of the Registrant and WellCare Health Plans, Inc., respectively, which are on file with the SEC, are incorporated herein by reference (except for the portions thereof “furnished” but not “filed” or otherwise not filed with the SEC which are deemed not to be incorporated by reference into this Registration Statement):

Registrant


a)
Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on February 19, 2019;

3


b)
Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2019, June 30, 2019 and September 30, 2019, filed with the SEC on April 23, 2019, July 23, 2019 and October 22, 2019, respectively;


c)


d)
Exhibit 99.1 to Current Report on Form 8-K filed on March 26, 2018;


e)
The description of common stock contained in the Registrant’s registration statement on Form 8-A filed with the SEC on October 14, 2003, as amended by the Registrant’s Forms 8-A/A filed with the SEC on December 17, 2004 and April 26, 2007, including any amendments or reports filed for the purpose of updating such description.

WellCare Health Plans, Inc.


a)
Annual Report on Form 10-K for the year ended December 31, 2018 (only Item 15(c)), filed with the SEC on February 12, 2019;


b)
Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019 (only Item 1), filed with the SEC on October 30, 2019;


c)
Exhibit 99.4 to Current Report on Form 8-K filed on August 6, 2018;


d)
Exhibit 99.2 to Current Report on Form 8-K/A filed on October 30, 2018.

All documents filed by the Registrant with the SEC pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), subsequent to the date hereof and prior to the filing of a post-effective amendment hereto which indicates that all securities offered hereunder have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents except that the portion of any document “furnished” but not “filed” shall not be incorporated by reference herein.

For purposes of this Registration Statement, any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated herein by reference modifies or supersedes such statement in such document. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

Item 4.
Description of Securities.

Not applicable.

Item 5.
Interests of Named Experts and Counsel.

None.

Item 6.
Indemnification of Directors and Officers.

Section 145 of the Delaware General Corporation Law (the “DGCL”) permits a corporation to indemnify any person who is or has been a director, officer, employee or agent of the corporation or who is or has been serving as director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise at the request of the corporation, against expenses (including attorneys’ fees), judgments, fines, penalties, and amounts paid in settlement actually and reasonably incurred in connection with any civil, criminal, administrative or investigative action, suit or proceeding (other than an action by or in the right of the corporation) in which such person is involved by reason of the fact that he or she served or is serving in these capacities, if such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interest of the corporation and, with respect to any criminal action or proceeding, had no cause to believe his or her conduct was unlawful. In the case of an action or suit made or brought by or in the right of the corporation to procure a judgment in its favor, the corporation shall not indemnify such person in respect of any claim, issue or matter as to which such person has been adjudged to be liable to the corporation, except for such expenses as the court may allow. To the extent that such person has been successful on the merits or otherwise in defending any such action, suit or proceeding referred to above or any claim, issue or matter therein, he or she is entitled to indemnification for expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection therewith.

4

Section 102(b)(7) of the DGCL provides that a corporation may eliminate or limit the personal liability of a director to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, provided that such provision shall not eliminate or limit the liability of a director (i) for any breach of the director’s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) under Section 174 of the DGCL or (iv) for any transaction from which the director derived an improper personal benefit. No such provision shall eliminate or limit the liability of a director for any act or omission occurring prior to the date when such provision becomes effective.

Pursuant to Article Sixth and Seventh of its Certificate of Incorporation and Article VIII of its Amended and Restated By-Laws (the By-Laws), the Registrant will indemnify and hold harmless directors and officers who were or are made or are threatened to be made a party or are otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative, to the fullest extent permitted by applicable law as it presently exists or is amended. The Registrant has entered into agreements with directors and officers requiring it to indemnify such persons to the fullest extent permitted by the By-Laws. The Registrant also maintains insurance coverage relating to certain liabilities of directors and officers.

Item 7.
Exemption from Registration Claimed.

Not applicable.

Item 8.
Exhibits.

The Exhibits to this Registration Statement are listed in the Exhibit Index to this Registration Statement, which is incorporated herein by reference.

Item 9.
Undertakings.

(a)    The undersigned Registrant hereby undertakes;

(1)  To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

(i)   To include any prospectus required by Section 10(a)(3) of the Securities Act;

(ii)  To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement; and

5

(iii) To include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in the Registration Statement;

provided, however, that the undertakings set forth in paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement;

(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(b)    The undersigned Registrant hereby further undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act and, where applicable, each filing of the Plan’s annual report pursuant to Section 15(d) under the Exchange Act, that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(c)    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

6

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the city of Clayton, State of Missouri, on January 23, 2020.

 
CENTENE CORPORATION
     
 
By:
   
   
Chairman, President and Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Michael F. Neidorff and Jeffrey A. Schwaneke, or either of them, his or her true and lawful attorney-in-fact and agent, each with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments (including, without limitation, post-effective amendments and documents in connection therewith) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, and hereby grants to such attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary or desirable to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

Signature
 
Title
 
Date
         
 
Chairman, President and Chief Executive Officer
 
 
(Principal Executive Officer)
   
         
 
Executive Vice President and Chief Financial Officer
 
 
(Principal Financial Officer)
   
         
 
Senior Vice President, Corporate Controller and Chief Accounting Officer
 
 
(Principal Accounting Officer)
   
         
 
Director
 
       
         
 
Director
 
       
         
 
Director
 
       

7

 
Director
 
       
         
 
Director
 
       
         
 
Director
 
       
         
 
Director
 
       
         
/s/ Lori J. Robinson
 
Director
 
Lori J. Robinson        
         
 
Director
 
       
         
 
Director
 
       
         
 
Director
 
       

8

EXHIBIT INDEX

Exhibit
Number
 
Description
     
 
Certificate of Incorporation of Centene Corporation (incorporated by reference to Exhibit 3.2 to the Registrant’s Form S-1 filed October 9, 2001).
     
 
Certificate of Amendment to Certificate of Incorporation of Centene Corporation, dated November 8, 2001 (incorporated by reference to Exhibit 3.2a to Form S-1/A filed November 13, 2001).
     
 
Certificate of Amendment to Certificate of Incorporation of Centene Corporation as filed with the Secretary of State of the State of Delaware (incorporated by reference to Exhibit 3.1b to Form 10-Q filed July 26, 2004).
     
 
Certificate of Amendment to Certificate of Incorporation of Centene Corporation as filed with the Secretary of State of the State of Delaware (incorporated by reference to Exhibit 3.1c to Form S-3ASR filed May 16, 2014).
     
 
Certificate of Amendment to Certificate of Incorporation of Centene Corporation as filed with the Secretary of State of the State of Delaware (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on October 26, 2015).
     
 
Certificate of Amendment to Certificate of Incorporation of Centene Corporation as filed with the Secretary of State of the State of Delaware (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 7, 2019).
     
 
By-laws of Centene Corporation, as amended and restated effective October 22, 2019 (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on October 23, 2019).
     
4.1
  Centene Corporation 2012 Stock Incentive Plan, as amended (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on April 27, 2017).
     
 
2013 Incentive Compensation Plan of WellCare Health Plans, Inc. (incorporated by reference from Appendix A to WellCare Health Plans, Inc.’s Proxy Statement on Form DEF 14A filed on April 10, 2013).
     
 
2019 Incentive Compensation Plan of WellCare Health Plans, Inc. (incorporated by reference from Appendix A to WellCare Health Plans, Inc.’s Proxy Statement on Form DEF 14A filed on April 8, 2019).
     
 
Amendment No. 1 to the 2019 Incentive Compensation Plan of WellCare Health Plans, Inc., dated as of January 23, 2020.*
     
 
Opinion of Counsel.
     
 
Consent of KPMG LLP, independent registered public accounting firm of Centene Corporation.
     
 
Consent of Deloitte & Touche LLP, independent registered public accounting firm of WellCare Health Plans, Inc.
     
 
Consent of Deloitte & Touche LLP, independent registered public accounting firm of New York State Catholic Health Plan, Inc. (d/b/a Fidelis Care New York).
     
 
Consent of Plante & Moran PLLC, independent auditor of Caidan Enterprises, Inc.
     
 
Consent of Counsel (included in Exhibit 5.1).
     
 
Power of Attorney (included on signature page).

*Filed herewith.


9


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-8’ Filing    Date    Other Filings
Filed on / Effective on:1/23/208-K
1/21/208-K
10/30/19
10/23/193,  4,  425,  8-K
10/22/1910-Q,  3,  4,  425,  8-K
9/30/1910-Q,  4
6/30/1910-Q,  4
4/8/19
3/31/1910-Q,  4
3/26/194,  8-K
2/19/1910-K,  4
2/12/19
2/7/194,  8-K
12/31/1810-K,  4,  5
10/30/18
8/6/18
3/26/188-K
4/27/174,  8-K
10/26/1510-Q,  425,  8-K
5/16/14S-3ASR
4/10/13
7/26/0410-Q,  4,  8-K
11/13/01S-1/A
11/8/01
10/9/01S-1
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/22  Centene Corp.                     10-K       12/31/21  123:15M
 2/22/21  Centene Corp.                     10-K       12/31/20  120:15M
Top
Filing Submission 0001140361-20-001319   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 2:24:05.2pm ET